Healthcare Technology Company Announces Positive Clinical Update From Cancer Trial
Lantern Pharma Announces Positive Clinical Update from Phase 2 HARMONIC™ Clinical Trial.
Disclaimer: The following article provides an overview of the clinical update announced by Lantern Pharma regarding their ongoing Phase 2 HARMONIC™ clinical trial for never smokers with advanced non-small cell lung cancer (NSCLC). The content herein is intended for informational purposes only and does not constitute medical advic…